Related Experiment Video
Updated: Jun 11, 2026

Extraction and Characterization of Surfactants from Atmospheric Aerosols
Published on: April 21, 2017
Using quality-improvement methods to reduce variation in surfactant administration
Laurel Bookman1, Rachel Troy, Martin McCaffrey
1Division of Neonatology, Cincinnati Children's Hospital, MLC 7009, 3333 Burnet Avenue, Cincinnati, OH 45209, USA. laurelmed1@yahoo.com
Insights
Quality improvement methods significantly reduced the time to surfactant administration for premature infants. This enhanced timely treatment for respiratory distress syndrome in extremely low-birth-weight infants.
Area of Science:
- Neonatal care
- Quality improvement science
- Respiratory medicine
Background:
- Respiratory distress syndrome and chronic lung disease are common in extremely low-birth-weight infants.
- Timely surfactant administration is crucial for improving respiratory outcomes in these vulnerable infants.
Purpose of the Study:
- To evaluate the effectiveness of basic quality improvement methods in reducing the time to initial surfactant dose for premature infants.
- To assess the impact of process changes on surfactant delivery timeliness.
Main Methods:
- The study utilized Plan-Do-Study-Act cycles in a 48-bed neonatal intensive care unit (NICU).
- Intervention involved surfactant administration in the delivery room with a dedicated respiratory therapist.
- Data collected on infants born less than 27 weeks gestation.
Main Results:
- Surfactant was administered in the delivery room for 95% of eligible infants post-intervention.
- The mean time to initial surfactant dose decreased from 26 minutes to 10.2 minutes (p=0.0004).
- Variation in the timing of surfactant administration was also reduced.
Conclusions:
- Quality improvement initiatives can effectively enhance the timeliness of surfactant administration in NICUs.
- These methods successfully reduced variability in treatment timing for premature infants.
- Further research is recommended to validate these findings across diverse NICU settings.
Background:
Respiratory distress syndrome and chronic lung disease are prevalent disorders in extremely low-birth-weight infants. Evidence demonstrates that timely surfactant administration improves respiratory outcomes.
Objective:
To assess whether basic quality-improvement methods can reduce the time to initial surfactant dose for premature infants.
Design/Methods:
The study was conducted in a 48-bed neonatal intensive care unit (NICU) within a midsize academic centre. The authors included infants less than 27 weeks born from May 2007 to November 2007. Prior to the intervention, we obtained baseline data on the timing of initial surfactant dose. The intervention was designed using a series of Plan-Do-Study-Act cycles. The authors changed the process of surfactant administration to include administration of surfactant in the delivery room and a respiratory therapist on the delivery room team. The primary outcome measures were percentage of eligible infants who received surfactant in the delivery room and minutes after delivery at which the initial dose of surfactant was administered.
Results:
After the authors changed the surfactant administration process, 20/21 (95%) of eligible infants received surfactant in the delivery room. The authors decreased the time after delivery of initial surfactant dose from a mean of 26 min to 10.2 min (p=0.0004). The variation in timing of the initial surfactant dose also decreased.
Conclusions:
The authors demonstrated that quality-improvement methods can be used to improve the timeliness and reduce variation in timing of surfactant administration within a NICU. Future studies should assess whether these results can be replicated in a variety of NICU settings.
More Related Videos
Related Concept Videos
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Dosage Regimen: Individualization
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Introduction to Statistical Process Control
Bioavailability Enhancement: Drug Solubility Enhancement

